Hirayama disease: three cases assessed by F wave, somatosensory and motor evoked potentials and magnetic resonance imaging not supporting flexion myelopathy.

Traumatic chronic injury of the cervical spinal cord caused by neck flexion ("flexion myelopathy") is one of the suggested pathogenetic mechanisms for Hirayama disease (HD). Neurophysiological data, especially reporting particularly N13 cervical somatosensory response, are scarce and conflicting in HD. F wave, somatosensory evoked potentials (SEP), motor evoked potentials (MEP) and magnetic resonance imaging (MRI) studies were assessed in 3 HD male patients (aged 22, 36, and 51 years) with the aim of evaluating the functional effects of neck flexion in HD.

Utility of multimodal evoked potentials study in neurofibromatosis type 1 of childhood.

A group of 21 children affected by neurofibromatosis type 1 has been investigated with the aim of studying multimodal (visual, brainstem auditory, and somatosensory) evoked potentials and their correlations with neurologic, electroencephalographic, and cranial magnetic resonance imaging. In the present series, cranial magnetic resonance imaging and evoked potentials were the most frequently abnormal instrumental tests. In approximately two thirds of the cases at least one of the evoked potentials (particularly visual and auditory evoked potentials) was compromised, always without clinical signs of related sensory (visual, auditory, and somatosensory) pathway pathology and sometimes in the absence of magnetic resonance imaging signs of central nervous system involvement.

Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study.

A retrospective study was performed on 27 patients with hepatitis C (HCV)-related mixed cryoglobulinemia (purpura, arthralgia, hepatitis, glomerulonephritis, peripheral neuropathy) to assess peripheral nerve involvement during follow-up of up to 8 years. All patients had the same degree of organ/system involvement initially and were clinically evaluated at least annually. All 27 patients received steroids; 15 also received recombinant interferon-alpha 2b (rIFN-alpha 2b).